Cargando…

p53 and angiogenesis in non-small-cell lung cancer.

Detalles Bibliográficos
Autores principales:	Giatromanolaki, A., Koukourakis, M. I.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1998
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149961/ https://www.ncbi.nlm.nih.gov/pubmed/9514069

Ejemplares similares

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
por: O'Byrne, K J, et al.
Publicado: (2000)

Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.
por: Koukourakis, M. I., et al.
Publicado: (1997)

p53 and angiogenesis in non-small-cell lung cancer: Reply to the letter from Giatromanolaki and Koukourakis
por: Fontanini, G
Publicado: (1998)

Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer
por: Giatromanolaki, Alexandra, et al.
Publicado: (2022)

The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer
por: Giatromanolaki, Alexandra, et al.
Publicado: (2021)

iNOS Expression by Tumor-Infiltrating Lymphocytes, PD-L1 and Prognosis in Non-Small-Cell Lung Cancer
por: Giatromanolaki, Alexandra, et al.
Publicado: (2020)

Thermogenic protein UCP1 and UCP3 expression in non-small cell lung cancer: relation with glycolysis and anaerobic metabolism
por: Giatromanolaki, Alexandra, et al.
Publicado: (2017)

Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: correlation with regulatory FOXP3+T-cell tumour stroma infiltration
por: Giatromanolaki, Alexandra, et al.
Publicado: (2020)

Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.
por: Koukourakis, M. I., et al.
Publicado: (1998)

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
por: Koukourakis, M I, et al.
Publicado: (2003)

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
por: Giatromanolaki, A, et al.
Publicado: (2001)

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma
por: Koukourakis, M I, et al.
Publicado: (1999)

Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis
por: Sivridis, E, et al.
Publicado: (2002)

Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer
por: Koukourakis, M I, et al.
Publicado: (2012)

Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation
por: Tsolou, Avgi, et al.
Publicado: (2017)

Link between p53 isoforms and angiogenesis: Current prospects
por: Bid, Hemant Kumar
Publicado: (2013)

Repression of the autophagic response sensitises lung cancer cells to radiation and chemotherapy
por: Karagounis, Ilias V, et al.
Publicado: (2016)

Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head–Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy
por: Koukourakis, Ioannis M., et al.
Publicado: (2022)

Ultra-Hypofractionated Re-Irradiation with Anti-PD-1 Immunotherapy for Locoregionally Recurrent (after Radical Chemo-Radiotherapy) Non-Small Cell Lung Cancer
por: Filippatos, Konstantinos, et al.
Publicado: (2023)

Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?
por: Koukourakis, M I, et al.
Publicado: (2003)

Concurrent administration of Docetaxel and Stealth® liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection
por: Koukourakis, M I, et al.
Publicado: (2002)

Cancer Microenvironment Defines Tumor-Infiltrating Lymphocyte Density and Tertiary Lymphoid Structure Formation in Laryngeal Cancer
por: Gkegka, Anastasia G., et al.
Publicado: (2022)

Plasma Long Non-Coding RNA RP11-438N5.3 Level for Non-Small Cell Lung Cancer Diagnosis [Letter]
por: Yang, Chun-Qiu, et al.
Publicado: (2020)

Tumor Microenvironment and Immune Response in Lip Cancer
por: Gkegka, Anastasia G., et al.
Publicado: (2023)

Capsaicin-Induced Activation of p53-SMAR1 Auto-Regulatory Loop Down-Regulates VEGF in Non-Small Cell Lung Cancer to Restrain Angiogenesis
por: Chakraborty, Samik, et al.
Publicado: (2014)

Serum p53 antibodies: predictors of survival in small-cell lung cancer?
por: Murray, P V, et al.
Publicado: (2000)

Important Role of Autophagy in Endothelial Cell Response to Ionizing Radiation
por: Kalamida, Dimitra, et al.
Publicado: (2014)

Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve
por: Koukourakis, Michael I, et al.
Publicado: (2016)

Cutaneous squamous-cell carcinoma of the head-neck area refractory to chemo-radiotherapy: benefit from anti-PD-1 immunotherapy
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation
por: Rivas-Fuentes, Selma, et al.
Publicado: (2015)

Strategies targeting angiogenesis in advanced non-small cell lung cancer
por: Wang, Jun, et al.
Publicado: (2017)

Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers
por: Chang, Y-L, et al.
Publicado: (2003)

Fever-Range Hyperthermia vs. Hypothermia Effect on Cancer Cell Viability, Proliferation and HSP90 Expression
por: Kalamida, Dimitra, et al.
Publicado: (2015)

Angiogenesis Inhibitors in Small Cell Lung Cancer
por: Montanino, Agnese, et al.
Publicado: (2021)

Angiogenic Factor Expression in Hepatic Cirrhosis
por: Giatromanolaki, Alexandra, et al.
Publicado: (2007)

Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy
por: Koukourakis, M I, et al.
Publicado: (2014)

Human Papillomavirus in Endometrial Adenocarcinomas: Infectious Agent or a Mere “Passenger”?
por: Giatromanolaki, A., et al.
Publicado: (2007)

Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2
por: Tung, Min-Che, et al.
Publicado: (2015)

DRAM2 acts as an oncogene in non-small cell lung cancer and suppresses the expression of p53
por: Wudu, Muli, et al.
Publicado: (2019)

Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
por: Jung, Sangyong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_chqe8liq79a728rp2p9fieo9u6